[#DIV28SUPER] Help Establish Standard Data Collection Protocols for COVID-19 Research: Crowdsourcing Phase 3, Due Oct 2

Help Establish Standard Data Collection Protocols for COVID-19 Research Welcome to PhenX COVID-19 Crowdsourcing Phase 3 Open until Friday, October 2 Phase 3 requests that you select one protocol that best addresses each topic.     There are 2 groups of topics: Group 1: Demographics, Impacts, and Coping (18 topics) Group 2: Health, Access to Care and Mental Health (23 topics)   We ask that you respond to the group of topics that most closely reflects your expertise.  Of course, you can choose to respond to both groups of topics.  Step 1: Review Protocols For each topic, the individual protocol options are available for you to review: View protocols for Group 1 here View protocols for Group 2 here   Step 2: Pick the Top Protocols Click here for Phase 3 Group 1: (Time Estimate: 30 - 60 minutes) Click here for Phase 3 Group 2: (Time Estimate: 35 - 70 minutes) Phase 3 incorporates the sub-topics that were validated in Phase 2. Collaborators in the PhenX COVID-19 project include the U.S. National Institutes of Health (NIH) Office of Behavioral and Social Sciences Research (OBSSR), the National Institute of Environmental Health Sciences (NIEHS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Allergy and Infectious Diseases (NIAID), the National Library of Medicine (NLM), and the National Human Genome Research Institute (NHGRI). Disaster Research Response (DR2) serves as a repository for disaster-related data collection tools, including COVID-19 surveys. The PhenX Toolkit is a catalog of recommended measurement protocols suitable for use in a variety of research study designs involving human participants.    Funding PhenX is funded by the National Institutes of Health (NIH) Genomic Resource Grant (U41HG007050) from the National Human Genome Research Institute (NHGRI) with current or prior funding support from the National Institute on Drug Abuse (NIDA), the Office of Behavioral and Social Sciences Research (OBSSR), the National Institute of Mental Health (NIMH), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Minority Health and Health Disparities (NIMHD), the National Cancer Institute (NCI), and the Tobacco Regulatory Science Program (TRSP).

 

-------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L